What is pellet hormone replacement therapy, and who is eligible in Europe?

Pellet hormone replacement therapy explained: subcutaneous hormone implants, testosterone pellets, oestradiol pellets, dosing control, and prescribing criteria.

In this episode, we outline how pellet hormone therapy works and how doctors assess suitability under EU medical guidance.

You’ll learn:

• What hormone pellets are (small implants inserted under the skin)

• How they release testosterone or oestrogen over several months

• The difference between pellets and gels, patches, or injections

• Potential benefits and limitations of long-acting delivery

• Risks such as infection at insertion site, dosing inflexibility, or side effects

• Monitoring requirements: blood hormone levels, haematocrit, PSA (for men), breast and endometrial safety (for women)

• Situations where pellet therapy requests may be declined without confirmed hormonal deficiency

We explain how doctors assess symptoms, repeat laboratory confirmation, cardiovascular risk, cancer history, fertility plans, and alternative treatment options during an online consultation in the EU. Hormone therapy is prescribed only when diagnostic criteria are met and ongoing monitoring is available.

This episode reflects the clinical standards used by Mobi Doctor, where endocrine consultations are reviewed by a registered physician in line with EU prescribing guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/what-is-pellet-hormone-replacement-therapy